Profiling of coronaviral Mpro and enteroviral 3Cpro specificity provides a framework for the development of broad‐spectrum antiviral compounds

• Published in: Protein science Vol. 33; no. 9; pp. e5139 - n/a
• Main Authors: Rut, Wioletta, Groborz, Katarzyna, Sun, Xinyuanyuan, Hilgenfeld, Rolf, Drag, Marcin
• Format: Journal Article
• Language: English
• Published: Hoboken, USA John Wiley & Sons, Inc 01.09.2024; Wiley Subscription Services, Inc
• Subjects: Amino acids; Antiviral agents; Chemical activity; Combinatorial analysis; Combinatorial chemistry; Coronaviridae; Coronaviruses; COVID-19; Enteroviruses; Polyproteins; Protease; Severe acute respiratory syndrome coronavirus 2; Substrate inhibition; Substrate specificity; Viral diseases; viral proteases
• ISSN: 0961-8368; 1469-896X; 1469-896X
• DOI: 10.1002/pro.5139

The main protease from coronaviruses and the 3C protease from enteroviruses play a crucial role in processing viral polyproteins, making them attractive targets for the development of antiviral agents. In this study, we employed a combinatorial chemistry approach—HyCoSuL—to compare the substrate specificity profiles of the main and 3C proteases from alphacoronaviruses, betacoronaviruses, and enteroviruses. The obtained data demonstrate that coronavirus Mpros exhibit overlapping substrate specificity in all binding pockets, whereas the 3Cpro from enterovirus displays slightly different preferences toward natural and unnatural amino acids at the P4‐P2 positions. However, chemical tools such as substrates, inhibitors, and activity‐based probes developed for SARS‐CoV‐2 Mpro can be successfully applied to investigate the activity of the Mpro from other coronaviruses as well as the 3Cpro from enteroviruses. Our study provides a structural framework for the development of broad‐spectrum antiviral compounds.